Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3584 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lannet dismayed by delay to FDA’s decision

The FDA is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over

Elastin Specialties to partner with Novozymes

Elastin Specialties holds patents around the production and use of proteins based on human elastin sequences and proteins of similar type. Key attributes of these proteins is that

Proteolix initiates Phase I study of carfilzomib

Texas Accelerated Research is participating in the study under the leadership of Dr Kyriakos Papadopoulos. This trial would be evaluating single agent carfilzomib, a novel proteasome inhibitor, in

First generic versions of Trileptal get FDA approval

Oxcarbazepine tablets, available in strengths of 150mg, 300mg and 600mg, are manufactured by Roxane Laboratories, Glenmark Pharmaceuticals and Sun Pharmaceutical Industries. The labeling of the generic products may